Want to see HK:0108 full AI Analyst Report?
Top Page
GR Properties Limited
(0108)
Select Model
Select Model
Rating:52Neutral
Price Target:
HK$2.50
▲(30.89% Upside)
Action:Reiterated
Date:09/09/26
The score is primarily held back by weak and volatile profitability and higher leverage, despite improving cash generation. Technicals add moderate support as short-term momentum is positive, but the longer-term trend remains below key moving averages. Valuation is difficult to assess due to negative earnings and the absence of dividend yield data.
Positive Factors
Improving cash generation
Positive operating cash flow across the latest three years and strong 2025 free cash flow show improved cash conversion despite reported losses. If sustained, this internally generated liquidity can support operations, reduce reliance on external funding, and provide greater resilience through the next several quarters.
Negative Factors
Persistent net losses
Repeated annual losses and a deeply negative 2025 net margin indicate that bottom-line profitability is not yet dependable. This weak earnings record can limit retained capital, reduce financial flexibility, and make future performance more sensitive to non-operating or valuation-related swings.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving cash generation
Positive operating cash flow across the latest three years and strong 2025 free cash flow show improved cash conversion despite reported losses. If sustained, this internally generated liquidity can support operations, reduce reliance on external funding, and provide greater resilience through the next several quarters.
Read all positive factors
GR Properties Limited (0108) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$7.51B
Dividend YieldN/A
Average Volume (3M)808.73K
Price to Earnings (P/E)―
Beta (1Y)1.19
Revenue Growth24.51%
EPS Growth80.28%
CountryHK
Employees428
SectorReal Estate
Sector Strength53
IndustryReal Estate - Services
Share Statistics
EPS (TTM)-0.06
Shares Outstanding3,321,374,000
10 Day Avg. Volume477,400
30 Day Avg. Volume808,733
Financial Highlights & Ratios
PEG Ratio0.77
Price to Book (P/B)8.00
Price to Sales (P/S)21.48
P/FCF Ratio99.41
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
GR Properties Limited Business Overview & Revenue Model
Company Description
An investment holding company principally engaged in property-related businesses. The company operates through two segments: Property Development and Investment, and Property Management, which provides services for office buildings, residential pr...
How the Company Makes Money
null...
GR Properties Limited Financial Statement Overview
Summary
Income Statement
36
Negative
Balance Sheet
46
Neutral
Cash Flow
58
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 404.24M | 348.91M | 310.02M | 352.64M | 352.28M | 331.33M |
| Gross Profit | 397.35M | 347.44M | 220.08M | 275.88M | 279.56M | 250.04M |
| EBITDA | 27.19M | 18.88M | -840.68M | 61.70M | -194.62M | 245.17M |
| Net Income | -182.33M | -109.63M | -918.50M | -129.31M | -320.13M | 207.63M |
Balance Sheet | ||||||
| Total Assets | 6.26B | 5.74B | 5.42B | 6.41B | 6.24B | 6.89B |
| Cash, Cash Equivalents and Short-Term Investments | 231.06M | 312.76M | 311.31M | 316.82M | 365.00M | 304.05M |
| Total Debt | 4.04B | 2.89B | 1.91B | 2.70B | 2.39B | 2.17B |
| Total Liabilities | 5.17B | 4.80B | 3.29B | 3.31B | 2.99B | 3.03B |
| Stockholders Equity | 1.02B | 936.36M | 2.13B | 3.10B | 3.25B | 3.86B |
Cash Flow | ||||||
| Free Cash Flow | 103.04M | 75.38M | 79.13M | 103.25M | -179.96M | -32.50M |
| Operating Cash Flow | 147.57M | 121.78M | 80.28M | 104.22M | -179.04M | -31.63M |
| Investing Cash Flow | -56.67M | -214.24M | 7.95M | -327.49M | -136.66M | 64.19M |
| Financing Cash Flow | 34.97M | 14.28M | -199.13M | 173.70M | 351.88M | -43.75M |
GR Properties Limited Technical Analysis
Positive
1.91
Price Trends
1.83
Positive
1.95
Positive
2.35
Negative
Market Momentum
0.08
Negative
65.09
Neutral
77.70
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0108, the sentiment is Positive. The current price of 1.91 is below the 20-day moving average (MA) of 2.06, above the 50-day MA of 1.83, and below the 200-day MA of 2.35, indicating a neutral trend. The MACD of 0.08 indicates Negative momentum. The RSI at 65.09 is Neutral, neither overbought nor oversold. The STOCH value of 77.70 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:0108.
GR Properties Limited Peers Comparison
UnderperformOutperform
Sector (65)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$10.61B | 7.35 | 21.17% | 9.27% | 10.76% | -12.76% | |
71 Outperform | HK$6.78B | 9.86 | 3.22% | 5.43% | -10.82% | -1.24% | |
68 Neutral | HK$89.45B | -44.67 | -1.12% | 5.36% | -0.55% | -337.48% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
63 Neutral | HK$33.69B | 19.79 | 1.21% | 7.96% | 9.89% | -22.12% | |
55 Neutral | HK$564.12M | -13.84 | -0.94% | 7.03% | -0.96% | 91.94% | |
52 Neutral | HK$7.51B | -44.07 | -18.68% | ― | 24.51% | 80.28% |
* Real Estate Sector Average
HK:0108
GR Properties Limited
2.49
0.59
31.05%
HK:2669
China Overseas Property Holdings
3.24
-1.39
-29.99%
HK:0101
Hang Lung Properties
6.53
-1.59
-19.53%
HK:0071
Miramar Hotel & Investment Co
9.77
0.56
6.13%
HK:1997
Wharf Real Estate Investment Co
29.84
8.94
42.78%
HK:0225
Pokfulam Development Co. Ltd.
5.12
-0.52
-9.16%
GR Properties Limited Corporate Events
SR Medical Technology Appoints Veteran Engineer Shao Jiyou as Executive Director
Sep 16, 2026
SR Medical Technology Company Limited has appointed Mr. Shao Jiyou as an executive director, effective 16 September 2026. Shao, a professor-level senior engineer with extensive construction and corporate management experience and chairman of BCEG ...
SR Medical Technology Details Board and Committee Structure
Sep 16, 2026
SR Medical Technology Company Limited has outlined the current composition of its board, comprising six executive directors and three independent non-executive directors. The disclosure underscores the mix of management and independent oversight a...
SR Medical Technology Swings to Interim Loss Despite Double‑Digit Revenue Growth
Aug 31, 2026
SR Medical Technology Company Limited reported a strong top‑line performance for the six months ended 30 June 2026, with revenue rising 30.7% year on year to approximately HK$223.1 million. The increase reflects expansion in its medical tech...
SR Medical Technology flags sharp interim loss after cost surge
Aug 26, 2026
SR Medical Technology Company Limited has warned that it expects to post a loss attributable to shareholders of between HK$68 million and HK$73 million for the six months ended 30 June 2026, compared with a profit of about HK$2.1 million a year ea...
SR Medical Technology Sets Board Meeting to Approve Interim Results and Consider Dividend
Aug 19, 2026
SR Medical Technology Company Limited has scheduled a board meeting for 31 August 2026 to review and approve the interim results for the six months ended 30 June 2026. The board will also consider whether to declare, recommend or pay a dividend, a...
SR Medical Technology names seasoned finance executive as new CFO
Aug 13, 2026
SR Medical Technology Company Limited announced that chief financial officer Li Chenji will resign effective 13 August 2026 due to other business commitments, with the board noting there is no disagreement and no issues requiring shareholder atten...
SR Medical Technology Affirms Independence of Newly Appointed Board Director
Jul 21, 2026
SR Medical Technology Company Limited has announced supplemental details regarding the appointment of Mr. Huang Yining as an independent non-executive director, and as a member of the Audit, Nomination and Remuneration Committees. The company clar...
SR Medical Technology Rebrands With New Name, Ticker Short Names and Logo
Jul 21, 2026
SR Medical Technology Company Limited has formally changed its English and Chinese company names from GR Life Style Company Limited, effective 9 July 2026, and updated its corporate logo to align with the new branding. The move marks a clear repos...
GR Life Style Revamps Board with New Executive and Independent Directors
Jul 13, 2026
GR Life Style Company Limited has announced the resignation of independent non-executive director Leung Louis Ho Ming, who is stepping down from the board and its key committees in mid-July 2026 due to other business commitments, with the company ...
GR Life Style Company Details Board and Committee Structure
Jul 13, 2026
GR Life Style Company Limited has disclosed the current composition of its board of directors, listing five executive directors and three independent non-executive directors, and confirming their respective roles in overseeing the company. The ann...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.